AstraZeneca Earnings, Sales Beat Views

wsj.com AstraZeneca reiterated its full-year guidance after posting first-quarter core earnings and sales above forecasts.

A University of Oxford researcher is testing a revolutionary vaccine to prevent the onset of lung cancer

fortune.com The fight against cancer has been decades in the works, killing millions of people every year as researchers struggle to find a cure for the disease’s various mutations.…

3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge

investorplace.com Pharmaceutical companies with a deep pipeline of new molecular candiadates that will driven growth Big money tends to flow from one sector to the other. During the pandemic,…

3 Healthcare Mutual Funds To Grab As the Sector Continues to Rebound - SPDR Select Sector Fund

benzinga.com Healthcare did not have a great 2023, even as markets turned around from the depths of the year prior. The sector, which roughly accounts for 13% of the S&P 500, lagged last…

Shell fuels fears of London exodus as it considers move to New York

euronews.com Shell is considering a move to New York, as the divide widens between traditional investors, who want the company to focus on oil and gas, and activist investors, who want…

3 Blue-Chip Stocks to Buy as High Inflation Persists

investorplace.com You want these blue-chip stocks for inflation protection Inflation in the United States has been stubborn and a matter of concern for policymakers. For March, the consumer…

Canaan hires Pfizer executive, reels in $100M for biotech investing

finance.yahoo.com None Uwe Schoenbeck, a biotech veteran who most recently was chief scientific officer at Pfizer’s innovation division, has joined Canaan Partners as a venture partner, the…

Vital Science

businessinsider.com Getty Images / Insider Studios Government investment into research and development has helped the UK become a leader in life sciences, engineering biology, and artificial…

BioMarin tops LinkedIn list of best places to work in Ireland

siliconrepublic.com AstraZeneca, the British-Swedish pharmaceutical giant, and ServiceNow, the US-based software provider, took the second and third spot respectively as pharma and biotech…

3 Pharma Stocks That Are Money-Printing Machines in 2024

investorplace.com Buy these Pharma stocks to increase your portfolio's value The future of the U.S. economy appears promising, with robust growth and strong corporate performance. This…

4 Exceptional Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market

finance.yahoo.com It's been quite the journey for the investment community since this decade began. After four consecutive years of the major stock indexes trading off bear and bull markets,…

AstraZeneca CEO set to earn £18.7 million after shareholder backing

euronews.com More than 60% of shareholders backed the decision to raise Pascal Soriot’s pay packet, solidifying his position as the highest earning FTSE 100 boss. The chief executive of…

Health Care Roundup: Market Talk

wsj.com AstraZeneca, Alpine Immune Sciences and more in the latest Market Talks covering the Health Care sector.

The danger in saying yes to Pascal Soriot’s pay rise at AstraZeneca

theguardian.com Is Pascal Soriot, the chief executive of AstraZeneca, “massively underpaid”, as the chief investment officer of Florida-based GQG Partners, one of the company’s big…

Why Is AstraZeneca Stock Trading Higher Today?

benzinga.com Thursday, AstraZeneca Plc AZN raised its annualized dividend for 2024 by $0.20 to $3.10 per share, underlining the company’s confidence in its performance and cash…

Drugmaker AstraZeneca announces dividend hike ahead of vote on CEO’s pay package

theglobeandmail.com Drugmaker AstraZeneca AZN-Q plans to raise its annual dividend by 7 per cent for 2024, it said on Thursday, ahead of a shareholder vote on a hefty boost to its Chief…